Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Ys Biopharma Co. Ltd (YS)

Ys Biopharma Co. Ltd (YS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Ys Biopharma Co. Ltd BUILDING NO. 2 38 YONGDA ROAD DAXING BIOMEDICAL INDUSTRY PARK DAXING DISTRICT BEIJING F4 102629 CHN

www.ysbiopharm.com P: 010-892-0208

Description:

YS Biopharma Co. Ltd. is a biopharmaceutical company. It focuses on discovering, developing, manufacturing and commercializing new generations of vaccines and therapeutic biologics for infectious diseases and cancer. The company operates principally in China, the United States, Singapore, the United Arab Emirates and the Philippines. YS Biopharma Co. Ltd., formerly known as Summit Healthcare Acquisition Corp., is based in NEW YORK.

Key Statistics

Overview:

Market Capitalization, $K 71,655
Enterprise Value, $K 88,695
Shares Outstanding, K 93,058
Annual Sales, $ 100,000 K
Annual Net Income, $ -21,170 K
Last Quarter Sales, $ 13,640 K
Last Quarter Net Income, $ -14,680 K
EBIT, $ -10,690 K
EBITDA, $ -14,940 K
60-Month Beta 0.52
% of Institutional Shareholders 52.64%
Float, K 93,058
% Float 100.00%
Short Volume Ratio 0.28

Growth:

1-Year Return -64.26%
3-Year Return 0.00%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.16 on 01/22/24
Latest Earnings Date 04/19/24
Earnings Per Share ttm 0.03
EPS Growth vs. Prev Qtr -60.00%
EPS Growth vs. Prev Year -172.73%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

YS Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % 0.00%
Profit Margin % -21.17%
Debt/Equity 1.16
Price/Sales 0.91
Price/Cash Flow N/A
Price/Book 1.10
Book Value/Share 0.72
Interest Coverage -3.68
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar